Download Brochure
Login
Agenda at a Glance
Value-Driven Pharma Event Agenda
| DAY ONE: THURSDAY, OCTOBER 21, 2010 | |
| 7:30 | Registration and Morning Coffee |
| 8:15 | Chairperson’s Opening Remarks Robert Nauman, Principal, BIOPHARMA ADVISORS |
| 8:30 | CMS Industry Update – CER, HTA and Beyond Barry M. Straube, MD, Acting Chief Medical Officer, Acting Director, OFFICE OF CLINICAL STANDARDS & QUALITY CENTERS FOR MEDICARE & MEDICAID SERVICES (invited) |
| 9:00 | “Bending the Cost Curve” – How Healthcare Reform is Changing Business Practices Joshua Cohen, Senior Research Fellow, TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT |
| 10:00 | Understand How Patients Measure the Value of Treatments and Make Healthcare Decisions Thomas Goetz, Author of The Decision Tree blog and of the new book, The Decision Tree: Taking Control of Your Health in the New Era of Personalized Medicine and Executive Editor, Wired Magazine. |
| 11:00 | 30-Minute Networking & Refreshment Break BOOK SIGNINGS BY: Thomas Goetz, Author, The Decision Tree: Taking Control of Your Health in the New Era of Personalized Medicine Elizabeth Bewley, Author, Killer Cure: Why Health Care is the Second Leading Cause of Death in America And How to Ensure That It’s Not Yours |
| 11:30 | Leverage CER Data to Overcome Communication Obstacles and Successfully Execute Your Value Proposition |
| 12:30 | Networking Luncheon for All Participants |
| 1:30 | Develop Your Clinical Trials Dossier to Drive Innovation and Deliver Expected Value Metrics to Stakeholders Susan W. Sharpless, Director, Payer New Product Development, GLAXOSMITHKLINE |
| 2:15 | Defining , Demonstrating, and Measuring Value Through Health Economics and Outcomes Research in a New Payer Environment Mark Jewell, PhD, President, EPI-Q |
| 3:00 | Networking & Refreshment Break |
| 3:15 | Navigate the Uncertain Waters of CER to Ensure Your Products Value and Benefit is Undisputable Dennis Meletiche, PharmD, Director, Health Outcomes & Market Access, EMD SERONO Carol Gaich, HTA, Research Scientist ELI LILLY & CO. Raymond Zastrow, MD, Medical Director, QUADMED |
| 4:00 | Assess Global Value-Based Models and Public Initiatives that Incentivize Cost-Effectiveness Dr. Karthik Anantharaman, Head-Medical Affairs, ABBOTT INDIA LTD |
| 4:45 | Reconcile Government and Patient Perspectives on Drug Valuation to Align Incentives Behind Improving Individual Health WORKING GROUP LEADERS: Catherine Melfi, PhD, Senior Director, Global Health Outcomes, ELI LILLY Elizabeth Bewley, President & CEO, PARIO HEALTH INSTITUTE Robert Kritzler, MD, Deputy Chief Medical Officer, JOHN HOPKINS HEALTHCARE LLC Government Representative (invited) |
| 5:45 | Market Insights Dinner Workshops Join dinner workshops for relaxed discussion & networking on one of two of the industry most pressing topics |
| DAY TWO: Friday, October 22, 2010 | |
| MORNING WORKSHOP | |
| 9:00 -11:00 | CLOSED DOOR HEALTH PLAN AND GOVERNMENT BREAKFAST WORKSHOP Where Are We Headed: Leverage Pharmacy Value-Based Benefit Design, Outcomes Based Contracting and Pockets of Innovation to Drive Pharma to Deliver Value as You Define It Randy Vogenberg, Executive Director, Biologic Finance & Access Council Program, JEFFERSON SCHOOL OF PUBLIC HEALTH Dexter Shurney, MD, Medical Director, Employee Health and Care Plan, VANDERBILT UNIVERSITY AND MEDICAL CENTER |
| 9:00 | Chairperson’s Welcome and Opening Remarks Robert Nauman, Principal, BIOPHARMA ADVISORS |
| 9:15 | Solidify Relationships with R&D in Early Development to Communicate a Cohesive and Consistent Value Proposition to Your Stakeholders Pasquale Cetera, Group Vice President, Commercial Development, Global Pharmaceutical Business, MERCK |
| 10:00 | Develop Outcomes Based Pricing Agreements to Secure Market Share and Deliver Value to Payer Partners (Part I) Jean Pierre Altier, PhD, Former Vice President of Pricing & Reimbursement, PFIZER and Independent Consultant, ALTIER CONSULTING |
| 11:00 | Refreshment and Networking Break |
| 11:15 | Develop Outcomes Based Pricing Agreements to Secure Market Share and Deliver Value to Payer Partners (Part II) Ken LaPensee, Director, Health Economics, FOREST LABORATORIES INC |
| 12:00 | Interactive Roundtable Luncheon |
| 1:00 | INTERACTIVE FOCUS GROUP |
| Pharma and Payer Debate On Value Delivery and Assessment to Achieve Formulary Placement Moderator: Allan Korn, MD, FACP, Chief Medical Officer, Vice President, Clinical Affairs, BLUE CROSS BLUE SHIELD ASSOCIATION (BCBSA) | |
| 2:00 | Implement Adherence and Data Collection Strategies to Reduce the Time and Cost of “Right Person, Right Drug, Right Time” |
| 2:30 | Capture Value through Strategic Pricing to Communicate Value to Patients Steven Richardson, MD, MS, Former National Medical Director, GLAXOSMITHKLINE |
| 3:00 | Chairperson’s Recap and Industry Vision Robert Nauman, Principal, BIOPHARMA ADVISORS |
| 3:30 | Conference Concludes |
| Home | Register | Brochure | Related Events |
| ©2009-2010 IIR HOLDINGS, LTD. All Rights Reserved. | |||